https://www.wikidoc.org/index.php?title=Promegapoietin&feed=atom&action=historyPromegapoietin - Revision history2024-03-29T12:51:05ZRevision history for this page on the wikiMediaWiki 1.40.0https://www.wikidoc.org/index.php?title=Promegapoietin&diff=603557&oldid=prevWikiBot: Protected "Promegapoietin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))2011-09-27T18:18:51Z<p>Protected "<a href="/index.php/Promegapoietin" title="Promegapoietin">Promegapoietin</a>": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))</p>
<p><b>New page</b></p><div>'''Promegapoietin''' is a drug given during [[chemotherapy]] to increase [[blood cell]] regeneration. It is a [[colony-stimulating factor]] that stimulates [[megakaryocyte]] production.<ref>{{cite journal |author=Kratz-Albers K, Scheding S, Möhle R, Bühring H, Baum C, Mc Kearn J, Büchner T, Kanz L, Brugger W |title=Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin |journal=Exp Hematol |volume=28 |issue=3 |pages=335-46 |year=2000 |pmid=10720698}}</ref><ref>http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=46019</ref><br />
<br />
It functions by stimulating ligands for [[interleukin 3]] and [[c-Mpl]].<ref>{{cite journal |author=Doshi P, Giri J, Abegg A, Favara J, Huynh M, Kahn L, Minnerly J, Pegg L, Villani-Price D, Siegel N, Staten N, Thomas J, McKearn J, Smith W |title=Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways |journal=Exp Hematol |volume=29 |issue=10 |pages=1177-84 |year=2001 |pmid=11602319}}</ref><br />
<br />
==References==<br />
<references/><br />
<br />
==External links==<br />
* {{MeshName|promegapoietin-1a}}<br />
<br />
{{pharma-stub}}<br />
<br />
[[Category:Drugs]]<br />
[[Category:Cytokines]]</div>WikiBot